Computational design of a multi-epitope vaccine for Plasmodium falciparum using immunoinformatics
Scientific African · 2026-06 · 32 · e03429
DOI: 10.1016/j.sciaf.2026.e03429 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific African, 2026-06. Verfasst von Lindiwe Khumbuzile Zuma und 3 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: South African Agency for Science and Technology Advancement, National Research Foundation, South African Medical Research Council.
Abstract (Originalsprache)
The malaria Plasmodium falciparum ( P. falciparum ) strain continues to be a global health burden and accounts for more than 90 % of malaria-related deaths. Currently, the two implemented malaria vaccines have several drawbacks. Therefore, the development of a new generation of effective multi-targeting malaria vaccines is essential. This study aimed to develop a multi-epitope vaccine targeting the blood stage of P. falciparum using immunoinformatics. An array of bioinformatics tools was used to predict B-cell, HTL, and CTL epitopes. Additionally, the antigenicity, non-toxicity, and non-allergenicity of the epitopes were predicted. These epitopes were selected for the vaccine construct and linked with β-defensin adjuvant to enhance the immune response. The tertiary structure of the vaccine construct was predicted using the I-TASSER server and refined using Galaxy refine. Molecular docking and molecular dynamics (MD) simulation studies were conducted to validate the possible interactions between the vaccine construct and toll-like receptor (TLR4). The designed vaccine construct was predicted to be an antigen, non-toxic and non-allergenic. The molecular docking results depicted vaccine-TLR4 interaction with a binding energy of -27.4 kcal/mol. MD simulation results showed higher RMSD fluctuation values of vaccine-TLR4 complex, confirming conformational changes. Immune simulation revealed B-cell proliferation, memory B-cell generation, and helper T-cell activation. In conclusion, the designed multi-epitope vaccine demonstrated promising immunogenic and physicochemical properties, suggesting its potential as a safe and effective candidate for the blood stage of P. falciparum . Nonetheless, these computational predictions require validation through comprehensive in vitro and in vivo studies in relevant models to confirm their efficacy, safety, and protective potential before clinical application.
Förderung
- South African Agency for Science and Technology Advancement
- National Research Foundation
- South African Medical Research Council
- South African Medical Research Council Division of Research Capacity Development
Zitieren
APA
Zuma, L. K., Machaba, K. E., Karpoormath, R., & Pooe, O. J. (2026). Computational design of a multi-epitope vaccine for Plasmodium falciparum using immunoinformatics. Scientific African, 32, e03429. https://doi.org/10.1016/j.sciaf.2026.e03429
Vancouver
Zuma LK, Machaba KE, Karpoormath R, Pooe OJ. Computational design of a multi-epitope vaccine for Plasmodium falciparum using immunoinformatics. Scientific African. 2026;32:e03429. doi:10.1016/j.sciaf.2026.e03429
BibTeX
@article{Zuma2026,
author = {Zuma, Lindiwe Khumbuzile and Machaba, Kgothatso Eugene and Karpoormath, Rajshekhar and Pooe, Ofentse Jacob},
title = {Computational design of a multi-epitope vaccine for Plasmodium falciparum using immunoinformatics},
journal = {Scientific African},
year = {2026},
volume = {32},
pages = {e03429},
doi = {10.1016/j.sciaf.2026.e03429}
}
EUVIMED